Guus Westra

Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting

N Feller, Vincent H. J. van der Velden, Rik A. Brooimans et al. · Blood Cancer Journal · 2013 · 73 citations · Full text

Interleukin-2 receptor alpha-chain (CD25) expression on leukaemic blasts is predictive for outcome and level of residual disease in AML

Monique Terwijn, N Feller, Anna van Rhenen et al. · European Journal of Cancer · 2009 · 70 citations

Hematological Malignancy, Leukaemic Blasts, Medicine +8

High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome

N Feller, Gerrit Jan Schuurhuis, M.A. van der Pol et al. · Leukemia · 2003 · 64 citations

Cell Therapy, Medicine, Poor Clinical Outcome +12

Early Apoptosis Largely Accounts for Functional Impairment of CD34 ⁺ Cells in Frozen-Thawed Stem Cell Grafts

Fransien de Boer, Angelika M. Dräger, Herbert M. Pinedo et al. · Journal of Hematotherapy & Stem Cell Research · 2002 · 61 citations

<i>IN VITRO</i> RESISTANCE TO CYTOSINE ARABINOSIDE, NOT TO DAUNORUBICIN, IS ASSOCIATED WITH THE RISK OF RELAPSE IN <i>DE NOVO</i> ACUTE MYELOID LEUKAEMIA

E. Klumper, Gert J. Ossenkoppele, Rob Pieters et al. · British Journal of Haematology · 1996 · 55 citations